http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2528892-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8224eb6544472d94d54626130cf00d3e |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-428 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4035 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473 |
filingDate | 2009-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3748541153551984e34a8d0b760debcb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9736d4eb2d87de36963218dade11c5f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8c420dfa25e5d8496d15cb21b47bbfc |
publicationDate | 2014-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2528892-C2 |
titleOfInvention | Veterinary anti-prolactin composition for ruminants |
abstract | FIELD: chemistry. n SUBSTANCE: group of inventions relates to use of an anti-prolactin veterinary composition for administering to ruminants during gestation in order to induce considerable reduction in lactation, mammary involution and for treating and/or preventing diseases or infections in mammary glands in ruminants. Said composition includes at least one anti-prolactin compound which is a dopamine receptor agonist, where the dopamine receptor agonist is an ergoline derivative selected from cabergoline, metergoline, lisurdine, bromocriptine, ergometrine and/or derivatives thereof or the dopamine receptor agonist, which is not an ergoline derivative, is selected from ropinirole, pramipexole, rotigotine, quinagolide, and/or a derivative thereof. A veterinary kit includes said composition and instructions. n EFFECT: group of inventions provides significant reduction in lactation and promotes mammary involution during gestation, thereby improving lactation dry-off, and also significantly improves the state of the udder, more successful regeneration of damaged secretory tissues of the udder, reduced incidences of diseases and/or infections within the mammary gland and, for example, ruminant mastitis during the next lactation periods. n 18 cl, 5 ex, 2 dwg |
priorityDate | 2008-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 172.